Market access and pricing

A market access plan considers more than price. We discuss the product’s purpose, available evidence of value, the decision-making environment and the partner’s commercial objectives. Lithuania, Latvia and Estonia are assessed as individual markets.

• Reviewing the starting market position and product alternatives.
• Planning the value presentation and information required.
• Discussing pricing scenarios and their assumptions.
• Coordinating launch stages and related activities.

A product overview, regulatory status, available clinical or other supporting evidence and intended markets provide a useful starting point. If a pricing or reimbursement strategy already exists, we discuss the questions involved in local adaptation.

The scope depends on the product category and stage of development. Planning connects regulatory work, medical information and commercial implementation.